Innovations in Retinal Scanning, Neural Imaging, Post-operative Imaging, MRI Diagnostics, Breast Cancer Imaging, and Drug Efficacy Assessing Tools

Share this:
Published: 22 Jun 2018

The latest issue of Medical Imaging and Diagnostics TOE profiles innovations profiles in the medical imaging and diagnostics industry. Some of the profiles covered include development of an MRI without using contrasting agents, combined digital breast screening for cancer diagnosis, artificial intelligence-based breast imaging, automated retinal scanning solution, neural imaging, and surgical site markers for improved post-operative imaging. Medical Imaging and Diagnostics TechVision Opportunity Engine (TOE)'s mission is to analyze and report new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of CT, MRI, NM, PET, Ultrasound and X-ray. In addition, relevant developments in fusion technologies, functional imaging technology, interventional cardiology and image guided surgery and healthcare IT related areas such as PACS, medical information storage, and disaster recovery/business continuance will also be covered. The Health and wellness cluster covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies and imaging technologies and platforms. Keywords: Magnetic resonance imaging, medical imaging, breast screening, HIV drugs, retinal scanning, breast imaging, ophthalmic disorders, surgical site markers, near-infrared imaging


Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..